These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 24456374)

  • 1. Current pharmacological treatment approaches for alcohol dependence.
    Müller CA; Geisel O; Banas R; Heinz A
    Expert Opin Pharmacother; 2014 Mar; 15(4):471-81. PubMed ID: 24456374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy of alcoholism - an update on approved and off-label medications.
    Soyka M; Müller CA
    Expert Opin Pharmacother; 2017 Aug; 18(12):1187-1199. PubMed ID: 28658981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.
    Palpacuer C; Duprez R; Huneau A; Locher C; Boussageon R; Laviolle B; Naudet F
    Addiction; 2018 Feb; 113(2):220-237. PubMed ID: 28940866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selecting an appropriate alcohol pharmacotherapy: review of recent findings.
    Castrén S; Mäkelä N; Alho H
    Curr Opin Psychiatry; 2019 Jul; 32(4):266-274. PubMed ID: 30973369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Developments in Pharmacotherapy of Alcoholism.
    Soyka M; Lieb M
    Pharmacopsychiatry; 2015 Jul; 48(4-5):123-35. PubMed ID: 25761458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing drugs for treatment of alcohol use disorder.
    Aubin HJ
    Int Rev Neurobiol; 2024; 175():153-185. PubMed ID: 38555115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder.
    Simpson TL; Malte CA; Dietel B; Tell D; Pocock I; Lyons R; Varon D; Raskind M; Saxon AJ
    Alcohol Clin Exp Res; 2015 May; 39(5):808-17. PubMed ID: 25827659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for alcohol dependence: status of current treatments.
    Franck J; Jayaram-Lindström N
    Curr Opin Neurobiol; 2013 Aug; 23(4):692-9. PubMed ID: 23810221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prazosin for Veterans with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence: A Clinical Trial.
    Petrakis IL; Desai N; Gueorguieva R; Arias A; O'Brien E; Jane JS; Sevarino K; Southwick S; Ralevski E
    Alcohol Clin Exp Res; 2016 Jan; 40(1):178-86. PubMed ID: 26683790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder.
    Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Ralevski E; Rounsaville B
    Biol Psychiatry; 2006 Oct; 60(7):777-83. PubMed ID: 17008146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential.
    Soyka M
    Expert Opin Pharmacother; 2016; 17(4):619-26. PubMed ID: 26810044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of alcohol reduction pharmacotherapy according to treatment duration in patients with alcohol dependence or alcohol use disorder: A systematic review and network meta-analysis.
    Kotake K; Hosokawa T; Tanaka M; So R; Banno M; Kataoka Y; Shiroshita A; Hashimoto Y
    Addiction; 2024 May; 119(5):815-832. PubMed ID: 38173342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis.
    Soyka M; Friede M; Schnitker J
    Pharmacopsychiatry; 2016 Mar; 49(2):66-75. PubMed ID: 26845589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological profile and clinical findings of nalmefene (Selincro
    Tadori Y
    Nihon Yakurigaku Zasshi; 2020; 155(2):113-119. PubMed ID: 32115477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment-refractory substance use disorder: Focus on alcohol, opioids, and cocaine.
    Soyka M; Mutschler J
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():148-61. PubMed ID: 26577297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid Receptor Antagonists in the Treatment of Alcoholism.
    Serecigni JG
    Adicciones; 2015 Sep; 27(3):214-30. PubMed ID: 26437315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of alcohol dependence: a review of the clinical data.
    Mann K
    CNS Drugs; 2004; 18(8):485-504. PubMed ID: 15182219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medications for the Treatment of Alcohol Dependence-Current State of Knowledge and Future Perspectives from a Public Health Perspective.
    Stokłosa I; Więckiewicz G; Stokłosa M; Piegza M; Pudlo R; Gorczyca P
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence.
    Sinclair JM; Chambers SE; Shiles CJ; Baldwin DS
    Drug Saf; 2016 Jul; 39(7):627-45. PubMed ID: 27023898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials.
    Palpacuer C; Laviolle B; Boussageon R; Reymann JM; Bellissant E; Naudet F
    PLoS Med; 2015 Dec; 12(12):e1001924. PubMed ID: 26694529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.